Elanco (ELAN) EVP awarded stock, options and disposes shares for taxes

Rhea-AI Filing Summary

Elanco Animal Health executive Grace McArdle reported new equity awards and related tax withholding transactions. On March 1, 2026 she received employee stock options for 29,025 shares and grants of 30,110 and 14,205 shares of common stock at no cost. A total of 12,337 shares of common stock at $26.40 per share were disposed of to cover tax liabilities. The options and restricted stock units vest in three equal installments on March 1, 2027, 2028, and 2029.

Insider Trade Summary

Net Buyer: 31,978 shares

Net Buy 4 txns

Insider McArdle Grace

Role EVP, MANUFACTURING AND QUALITY

Type	Security	Shares	Price	Value
Grant/Award	Employee Stock Option (right to buy)	29,025	$0.00	$0.00
Grant/Award	Common Stock	30,110	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	12,337	$26.40	$326K
Grant/Award	Common Stock	14,205	$0.00	$0.00

Holdings After Transaction: Employee Stock Option (right to buy) — 29,025 shares (Direct); Common Stock — 108,027 shares (Direct)

Footnotes (2)

1. F1. Grant of restricted stock units vesting as follows: one-third vesting on March 1, 2027, one-third vesting on March 1, 2028, and the remaining vesting on March 1, 2029.
2. F2. Grant of stock options vesting as follows: one-third vesting on March 1, 2027, one-third vesting on March 1, 2028, and the remaining vesting on March 1, 2029.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 03/03/2026 - 07:17 PM Learn about SEC filing dates

FAQ

What insider transactions did Elanco (ELAN) report for Grace McArdle?

Elanco reported that EVP Grace McArdle received new equity awards and had shares withheld for taxes. She was granted stock options and common shares at no cost, while 12,337 shares were disposed of at $26.40 to satisfy tax obligations.

How many Elanco (ELAN) stock options were granted to Grace McArdle?

Grace McArdle was granted 29,025 Elanco employee stock options. These options are equity awards with a right to buy shares and vest over time, aligning her long-term compensation with company performance through a multi‑year vesting schedule ending in 2029.

What common stock grants did Elanco (ELAN) award to Grace McArdle?

Elanco granted Grace McArdle 30,110 shares and a separate grant of 14,205 shares of common stock at no purchase price. These equity awards increase her direct share ownership and are structured to vest over three years starting in 2027.

Why were 12,337 Elanco (ELAN) shares disposed of in this Form 4?

The 12,337 Elanco common shares were disposed of to cover tax liabilities at $26.40 per share. This transaction is coded as a tax‑withholding disposition, meaning shares are surrendered to satisfy taxes rather than sold in an open‑market trade.

What is the vesting schedule for Grace McArdle’s Elanco (ELAN) equity awards?

Both the restricted stock units and stock options vest in three equal installments. One‑third vests on March 1, 2027, another third on March 1, 2028, and the remaining portion on March 1, 2029, creating a multi‑year retention structure.

How did Grace McArdle’s Elanco (ELAN) share ownership change after these transactions?

Following a grant of 30,110 shares, McArdle held 106,159 common shares, and after the 12,337‑share tax‑withholding disposition she held 93,822 common shares directly. These figures reflect reported direct ownership after each respective non‑derivative transaction on March 1, 2026.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McArdle Grace

(Last) (First) (Middle)

C/O ELANCO ANIMAL HEALTH INCORPORATED

450 ELANCO CIRCLE

(Street)

INDIANAPOLIS IN 46221

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Elanco Animal Health Inc [ ELAN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, MANUFACTURING AND QUALITY

3. Date of Earliest Transaction (Month/Day/Year)
03/01/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/01/2026		A		30,110	A	$0	106,159	D
Common Stock	03/01/2026		F		12,337	D	$26.4	93,822	D
Common Stock	03/01/2026		A		14,205(1)	A	$0	108,027	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$26.4	03/01/2026		A		29,025		(2)	03/01/2036	Common Stock	29,025	$0	29,025	D

Explanation of Responses:

1. Grant of restricted stock units vesting as follows: one-third vesting on March 1, 2027, one-third vesting on March 1, 2028, and the remaining vesting on March 1, 2029.

2. Grant of stock options vesting as follows: one-third vesting on March 1, 2027, one-third vesting on March 1, 2028, and the remaining vesting on March 1, 2029.

	/s/ Amy C. Seidel, as Attorney-in-Fact for Grace McArdle	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.